Prelude Capital Management, LLC Ptc Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $280,335 - $410,094	6,939 Added 83.71%	15,228 $619,000
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $316,308 - $405,000	8,289 New	8,289 $401,000
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $192,886 - $248,194	4,609 New	4,609 $231,000
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $62,348 - $87,932	-1,300 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $341,982 - $429,794	-7,531 Reduced 85.28%	1,300 $61,000
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $206,671 - $266,982	4,856 Added 122.16%	8,831 $448,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $847,835 - $1.55 Million	-26,192 Reduced 86.82%	3,975 $177,000
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $958,770 - $1.49 Million	29,757 Added 7257.8%	30,167 $1.45 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $1.49 Million - $2.13 Million	-44,163 Reduced 99.08%	410 $14,000
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $848,946 - $1.08 Million	23,968 Added 116.32%	44,573 $2.01 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $578,794 - $813,691	20,605 New	20,605 $776,000
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $2.33 Million - $3.63 Million	-78,071 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $877,603 - $1.24 Million	-25,888 Reduced 24.9%	78,071 $3.67 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $1.67 Million - $3.11 Million	-65,004 Reduced 38.47%	103,959 $3.51 Million
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $2.09 Million - $3.89 Million	-119,506 Reduced 41.43%	168,963 $4.57 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $1.62 Million - $2.24 Million	107,090 Added 59.04%	288,469 $4.81 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $3.05 Million - $3.92 Million	181,379	181,379 $3.63 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$418 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$361 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$356 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$338 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$331 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account